Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Benjamin L. Ebert, M.D., D.Phil.

Co-Author

This page shows the publications co-authored by Benjamin Ebert and Andrew Guirguis.
Connection Strength

1.612
  1. Lenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyond. Curr Opin Cell Biol. 2015 Dec; 37:61-7.
    View in: PubMed
    Score: 0.679
  2. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2021 May; 2(3):250-265.
    View in: PubMed
    Score: 0.245
  3. Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide. Sci Transl Med. 2021 Jan 06; 13(575).
    View in: PubMed
    Score: 0.243
  4. Small-molecule-induced polymerization triggers degradation of BCL6. Nature. 2020 12; 588(7836):164-168.
    View in: PubMed
    Score: 0.240
  5. CrbnI391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. Blood. 2018 10 04; 132(14):1535-1544.
    View in: PubMed
    Score: 0.205
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.